PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Nov-2019 RHÖN-KLINIKUM AG: project consortium receives Euro 3.8 million from the Innovation Fund of the Federal Joint Committee for improving the link between the different medical services for the treatment of patients with cardiac insufficiency RHÖN-KLINIKUM AG
04-Nov-2019 ADC Therapeutics Announces Publication of ADCT-402 Data in Clinical Cancer Research ADC Therapeutics SA
04-Nov-2019 Xlife Sciences AG: New project in the portfolio Xlife Sciences AG
04-Nov-2019 Vivoryon Therapeutics to Attend and Present at Investor Conferences in November 2019 Vivoryon Therapeutics AG
04-Nov-2019 Okayama University Research: Synthetic Compound Provides Fast Screening For Potential Drugs Okayama University
04-Nov-2019 Healthcare Support Remains Strong For Singaporeans With Advanced Breast Cancer, But Patients Call For Greater Disease Education, Survey Finds Novartis
03-Nov-2019 AstraZeneca Tops the First Pharmaceutical Invention Index IDEA Pharma
01-Nov-2019 Rapid Nutrition PLC: Robust platform for Growth Rapid Nutrition PLC
01-Nov-2019 Biohaven Pharmaceuticals Reports Third Quarter 2019 Financial Results And Recent Business Developments Biohaven Pharmaceutical Holding Company Ltd.
01-Nov-2019 Zur Rose Group AG increases public bond to CHF 200 million Zur Rose Group AG
01-Nov-2019 LPW Celebrates 15 Years Customizing Learning Solutions Worldwide LPW Training Services
01-Nov-2019 UKCPA launch revised and updated Handbook of Perioperative Medicines UK Clinical Pharmacy Association
01-Nov-2019 Nektar Therapeutics to Host Webcast Conference Call with Melanoma Specialist for Analysts & Investors During 2019 Society for Immunotherapy of Cancer 34th Annual Meeting Nektar Therapeutics
01-Nov-2019 RESTORE 1st Advanced Therapies Science Meeting RESTORE
01-Nov-2019 Change in the Executive Management Board of Medartis Medartis Holding AG
31-Oct-2019 The Importance of "Shop and Compare" During Medicare Annual Election Period MDX Hawai'i
31-Oct-2019 New England Journal of Medicine Publishes Results from Astellas' Phase 3 ADMIRAL Trial of XOSPATA® (gilteritinib) in Adult Patients with FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia(1) Astellas Pharma US, Inc.
31-Oct-2019 Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing Watson-Marlow Fluid Technology Group
31-Oct-2019 Vertex Announces European Medicines Agency Marketing Authorization Application Validation for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment in Cystic Fibrosis Vertex Pharmaceuticals
31-Oct-2019 New Study Illustrates the Limitations of Compounded Thyroid Hormones IBSA Pharma, Inc.